Embark

Overview
News
Animal Therapeutics?
Product stageSegments
Seed
?
Veterinary diagnostics
?

Embark is a canine DNA testing company that provides pet owners with insights into their dog's breed composition and genetic health. Founded in 2015 by the Boyko brothers, Ryan and Adam, Embark's mission is to help owners maximize the quality time spent with their dogs by enabling preventive care through genetic information.

Embark's DNA test screens for over 350 dog breeds, including 90% of American Kennel Club recognized breeds, as well as street dogs and breeds not accepted by the AKC. The test utilizes over 200,000 genetic markers to analyze a dog's DNA, enabling accurate breed identification results within the range of 95-99%. Additionally, Embark's test evaluates over 200 genetic health conditions, allowing pet owners and veterinarians to better understand and manage potential health risks.

Embark has made significant contributions to canine genetics research, including landmark discoveries related to inbreeding depression in golden retrievers, blue eye coloration in huskies, and hearing loss in rhodesian ridgebacks. Through partnerships with organizations like Cornell University's College of Veterinary Medicine, Embark continues to expand its research capabilities and data set, paving the way for future advancements in dog health.

To collect DNA samples, Embark provides pet owners with a simple cheek swab kit, which can be mailed back to the company's laboratory for analysis. The results are then presented to owners through an online dashboard, providing detailed breed composition breakdowns, a family tree spanning three generations, genetic health screening results, and other insights such as predicted adult weight and inbreeding scores.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
186 Lincoln St, 6th Floor Boston MA USA
Founded year:
2015
Employees:
101-250
IPO status:
Private
Total funding:
USD 94.3 mn
Last Funding:
USD 75.0 mn (Series B; Jul 2021)
Last valuation:
USD 700.0 mn (Jul 2021)
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.